- Home
- SONN vs SINT Comparison
SONN vs SINT Comparison
Compare SONN & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- SINT
- Stock Information
- Founded
- SONN N/A
- SINT 1996
- Country
- SONN United States
- SINT United States
- Employees
- SONN N/A
- SINT N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- SONN Health Care
- SINT Health Care
- Exchange
- SONN Nasdaq
- SINT Nasdaq
- Market Cap
- SONN 4.6M
- SINT 4.8M
- IPO Year
- SONN N/A
- SINT 2014
- Fundamental
- Price
- SONN $1.28
- SINT $2.59
- Analyst Decision
- SONN Strong Buy
- SINT Strong Buy
- Analyst Count
- SONN 2
- SINT 1
- Target Price
- SONN $38.00
- SINT $30.00
- AVG Volume (30 Days)
- SONN 31.5K
- SINT 67.2K
- Earning Date
- SONN 05-16-2025
- SINT 05-16-2025
- Dividend Yield
- SONN N/A
- SINT N/A
- EPS Growth
- SONN N/A
- SINT N/A
- EPS
- SONN N/A
- SINT N/A
- Revenue
- SONN $1,000,000.00
- SINT $2,887,000.00
- Revenue This Year
- SONN $5,376.22
- SINT N/A
- Revenue Next Year
- SONN N/A
- SINT N/A
- P/E Ratio
- SONN N/A
- SINT N/A
- Revenue Growth
- SONN 674.14
- SINT 9.90
- 52 Week Low
- SONN $1.10
- SINT $1.71
- 52 Week High
- SONN $16.00
- SINT $45.60
- Technical
- Relative Strength Index (RSI)
- SONN 44.48
- SINT 52.29
- Support Level
- SONN $1.30
- SINT $2.37
- Resistance Level
- SONN $1.37
- SINT $2.82
- Average True Range (ATR)
- SONN 0.09
- SINT 0.31
- MACD
- SONN -0.01
- SINT 0.06
- Stochastic Oscillator
- SONN 13.79
- SINT 64.10
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.